Naringenin treatment also induced cas3-dependent apoptosis in the melanoma cells, suppressed HUVECs migration and tube formation, and inhibited ex vivomicrovessel sprouting by regulating the mRNA expression of Tie-2 and Ang-2. The gene discussed is ANGPT2; the disease is melanoma.